BC

Bhavesh Chandulal Limbachiya

Active Director Director DIN 02403820
DIN 02403820 First appointment Nov 2008 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Total affiliations 5 Since Nov 2008
Shareholding value •••• Premium profile

About Bhavesh Chandulal Limbachiya

Data last updated:

Bhavesh Chandulal Limbachiya is a Director at Manisha Analytical Laboratories Private Limited (since 2014), Director at Bee Pharmo Labs Private Limited (since 2008) and Director at Hindustan Biosynth Limited (since 2014), and holds 2 more current directorships. The companies operate in Healthcare, Food and Beverages and Pharma. The 5 current companies with reported revenue have a combined latest revenue of ₹82.21 Cr; the largest is Manisha Analytical Laboratories Private Limited at ₹48.79 Cr (FY 2025).

DIN 02403820
Primary Designation Director
Industry Healthcare
First Appointment 10 Nov 2008
Oldest Company Age 38 yrs
Largest company Manisha Analytical Laboratories Private Limited · ₹48.79 Cr (FY 2025)
Combined revenue ₹82.21 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Aug 20141988₹48.79 Cr (FY 2025)Active
Bee Pharmo Labs Private Limited U73100MH1988PTC047818
Director10 Nov 20081988₹26.05 Cr (FY 2025)Active
Hindustan Biosynth Limited U24231GJ2004PLC043432
Director13 Mar 20142004₹6.98 Cr (FY 2025)Active
Hindustan Pharmachem Limited U24232GJ2003PLC042721
Director13 Mar 20142003₹27 Lakh (FY 2022)Active
Director13 Mar 20141994₹12.3 Lakh (FY 2022)Active

Directorship timeline

Open interactive timeline →
Health And Hygiene Products(India)Limited
Manisha Analytical Laboratories Private Limited
Hindustan Biosynth Limited
Hindustan Pharmachem Limited
Premium access

Shareholding and investment profile for Bhavesh Chandulal Limbachiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhavesh Chandulal Limbachiya

Bhavesh Chandulal Limbachiya currently holds 5 directorships: Manisha Analytical Laboratories Private Limited (Director, since 19 Aug 2014, revenue ₹48.79 Cr (FY 2025)); Bee Pharmo Labs Private Limited (Director, since 10 Nov 2008, revenue ₹26.05 Cr (FY 2025)); Hindustan Biosynth Limited (Director, since 13 Mar 2014, revenue ₹6.98 Cr (FY 2025)); Hindustan Pharmachem Limited (Director, since 13 Mar 2014, revenue ₹27 Lakh (FY 2022)); Health And Hygiene Products(India)Limited (Director, since 13 Mar 2014, revenue ₹12.3 Lakh (FY 2022)).

Bhavesh Chandulal Limbachiya was first appointed on 10 Nov 2008 as Director at Bee Pharmo Labs Private Limited. The most recent appointment on record is 19 Aug 2014 at Manisha Analytical Laboratories Private Limited.

The 5 current companies of Bhavesh Chandulal Limbachiya that report revenue have a combined latest revenue of ₹82.21 Cr: Manisha Analytical Laboratories Private Limited ₹48.79 Cr (FY 2025); Bee Pharmo Labs Private Limited ₹26.05 Cr (FY 2025); Hindustan Biosynth Limited ₹6.98 Cr (FY 2025); Hindustan Pharmachem Limited ₹27 Lakh (FY 2022); Health And Hygiene Products(India)Limited ₹12.3 Lakh (FY 2022).

The current boards of Bhavesh Chandulal Limbachiya's companies include Chandulal Hiralal Nai (Manisha Analytical Laboratories Private Limited), Rahul Chandulal Limbachiya (Manisha Analytical Laboratories Private Limited), Vinod Nayi Hiralal (Manisha Analytical Laboratories Private Limited), Swati Hiriyanna Shetty (Bee Pharmo Labs Private Limited), Sauhil Sudesh Bhattia (Hindustan Biosynth Limited), Sudeshkumar Banarasidas Bhatia (Hindustan Biosynth Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available